Home/Cytovation/Diane Cowie

DC

Diane Cowie

Head of CMC

Therapeutic Areas

Oncology Immunotherapy

Cytovation Pipeline

Drug	Indication	Phase
CY-101	Adrenocortical Carcinoma	Phase 2
CY-101 + Pembrolizumab	Colorectal Cancer	Phase 1/2

Leadership Team at Cytovation

Lars Prestegarden

Co-founder and Chief Executive Officer

Chief Operating Officer and Chief Financial Officer

View full Cytovation profile